Meeting
2014 ASCO Annual Meeting
A phase II study of whole brain radiotherapy with simultaneous integrated boost using volumetric modulated arc therapy for 1 to 10 brain metastases.
Authors
Alan Nichol
Princess Margaret Hospital
Alan Nichol , Michael R. McKenzie , Roy Ma , Fred Hsu , Arthur Cheung , Devin Schellenberg , Lovedeep Gondara , Rosemin Vellani , Hannah Carolan , Robert Anton Olson , Francois Germain
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Central Nervous System Tumors
Track
Central Nervous System Tumors
Sub Track
Central Nervous System Tumors
Clinical Trial Registration Number
NCT01046123
Citation
J Clin Oncol 32:5s, 2014 (suppl; abstr 2078)
DOI
10.1200/jco.2014.32.15_suppl.2078
Abstract #
2078
Poster Bd #
43
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Pretreatment clinical parameters associated with intracranial progression burden following an initial stereotactic radiosurgery course in a multi-institutional brain metastases cohort.
First Author: Christina C Huang
Poster
2023 ASCO Annual Meeting
Brain metastasis burden and management in small cell lung cancer: An analysis of 8705 patients.
First Author: Karolina Gaebe
Poster
2021 ASCO Annual Meeting
Predictors of overall survival (OS) in patients (pts) with melanoma brain metastasis (MBM) in the modern era.
First Author: Merve Hasanov
Poster
2021 ASCO Annual Meeting
Patterns of survival in NSCLC with de novo brain metastasis: SRS, WBRT, and no radiotherapy cohorts.
First Author: Diana Saravia